Therapeutic efficacy of the angiogenesis inhibitor O- (Chloroacetyl- carbamoyl) fumagillol (TNP-470; AGM-1470) for human anaplastic thyroid carcinoma in nude mice
- 31 August 1997
- journal article
- Published by Elsevier BV in Experimental and Toxicologic Pathology
- Vol. 49 (3-4), 239-247
- https://doi.org/10.1016/s0940-2993(97)80020-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM-1470Journal of Neurosurgery, 1993
- Production of Multiple Growth Factors by a Newly Established Human Thyroid Carcinoma Cell LineJapanese Journal of Cancer Research, 1992
- Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parentBiochemical and Biophysical Research Communications, 1991
- Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti‐cancer therapeutic agentsBioEssays, 1991
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- Angiogenic FactorsScience, 1987
- Treatment of anaplastic giant and spindle cell carcinoma of the thyroid gland with combination adriamycin and radiation therapy a new approachCancer, 1983
- Factor VIII related antigen as an endothelial cell marker in benign and malignant diseasesVirchows Archiv, 1981
- Chromosomes and causation of human cancer and leukemia. XLIV. A method for chromosome analysis of solid tumorsCancer Genetics and Cytogenetics, 1981
- Angiogenesis in vitroNature, 1980